INTRODUCTION
The p53 pathway is composed of hundreds of genes and their products that respond to a wide variety of stress signals. These responses to stress include apoptosis, cellular senescence or cell cycle arrest (1) . The p53 protein is employed as a transcriptional activator of p53-regulated genes. In addition, the p53-regulated genes produce proteins that communicate with adjacent cells, prevent and repair damaged DNA and set up positive and negative feedback loops that enhance or attenuate the functions of the p53 protein and communicate with other signal transduction pathways (2, 3) . In the p53 pathway, one of the most important upstream mediators of the p53 response is AP-1, which is composed of dimers of Fos and Jun proteins and has been linked to a startling breadth of cellular events including cell transformation, proliferation, differentiation and apoptosis (4, 5) . The downstream components in the p53 pathway are widely believed including the cancer suppressor p21 WAF1/CIP1 , which plays an important role in the control of the cell cycle by inhibiting all the cyclin-dependent kinases (CDK) (6, 7) . Many transcription factors have also been identified as components of the p53 pathway, including the family of sterile alpha motif (SAM)-containing proteins.
SAM is an evolutionary conserved protein binding domain that is involved in the regulation of numerous developmental processes among diverse eukaryotes (8) . SAM domains have been shown to form homo-and hetero-oligomers, forming multiple self-association structures that also bind to various non-SAM domain-containing proteins although with a low affinity (9) . SAM domains are protein-protein interaction domains that are able to bind other SAM domains as well as to SH2 domains via phosphorylation of a conserved tyrosine in SH2 domains. They occur in proteins involved in both signaling and developmental regulation (10) , and recent studies indicate that three SAM-containing proteins, Sqp53, p63 and p73, are likely to function in the p53 pathway (11, 12) . Whether any other SAM domain proteins are involved in the p53 pathway is unknown.
In this study, we isolated a novel human gene named SAMD4B, encoding a SAM domain-containing protein, from a human heart cDNA library. Northern blot and RT-PCR analysis indicates that SAMD4B is expressed in most of embryonic and adult tissues tested. The highest expression of mRNA was detected in adult testis and the lowest in adult liver. Reporter gene assays showed that SAMD4B was a transcriptional repressor. Overexpression of pCMV-Tag2B-SAMD4B in HEK-293 cells inhibited AP-1, p53 and p21-mediated transcriptional activities, and the inhibitory effects were relieved by siRNA. The results suggest that SAMD4B might play a role in p53 pathway, which is known to affect cell cycle and apoptosis. http://bmbreports.org p67, p73 and Sqp53, have been identified as playing important roles in regulating embryonic development (6) . To specifically study the function of the SAM containing proteins, we screened the human EST database with the conserved SAM motif. A series of ESTs, CR983898, BF768721, DN996769, CN394606 and CB852248, with high sequence similarity, were obtained. Homology comparison of those ESTs against human EST databases was carried out. A 5.1 kb fulllength cDNA sequence of a predicted novel human gene was obtained from these ESTs by splicing on an EST annotation machine at IFOM (http://bio.ifom-firc.it/EST_MACHINE/index.html). An ORF sequence containing these ESTs was obtained using Genscan software. Results of a comparison against the nr database showed that the sequence represented a novel gene, termed SAMD4B (GenBank accession number EF601121) as approved by HUGO Nomenclature Committee. To confirm the cDNA sequences identified from the database, the PCR was performed using specific primers pORF1/pORF2 (Supplement material Phylogenetic tree analysis of amino acid sequences deduced from SAMD4B DNA sequence was performed using the MegAlign program of DNASTAR. GenBank accession numbers of previously known members of the SAM domain-containing protein and the novel SAM gene sequences were used for this analysis and the results show that SAMD4B is one of the conserved proteins during evolution (Supplement material Fig. 1 ). The most closely related protein to SAMD4B is XP_001136382 (Pan troglodytes).
Expression of SAMD4B in human adult and embryonic tissues
In order to understand the expression pattern of the SAMD4B gene in various human tissues, the expression of SAMD4B in multiple human embryonic tissues was examined by RT-PCR. The results showed that the target bands were detected in all the embryonic tissues tested (Fig. 1A) . The expression profiles of the SAMD4B gene was also examined in adult tissues using northern blot analysis. The results indicated that a single expressed mRNA band of 5.1 kb was observed in various adult tissues, with a higher level in adult testis and lower in adult liver (Fig. 1B) . The results indicate that SAMD4B is expressed in multiple human embryonic and adult tissues.
Subcellular localization of the SAMD4B protein
To examine the subcellular distribution of SAMD4B, the pEGFP-N2-SAMD4B recombinant plasmid was constructed and transiently introduced into COS-7 cells by liposome transfection. Under fluorescence microscope, the green fluorescence produced by pEGFP-N2-SAMD4B was detected in the nucleus and cytoplasm of COS-7 cells labeled with DAPI for the nucleus 48 h post-transfection. As shown in (Fig. 1C-E) , this result suggested that SAMD4B protein distributes evenly in both the nucleus and the cytoplasm.
SAMD4B has transcriptional repressor activity
Although SAMD4B protein belongs to SAM domain-containing protein, the potential role of SAMD4B is not clear. To examine the transcriptional activity of SAMD4B, we constructed a fusion protein of SAMD4B with the DNA-binding domain (BD) of yeast transcription factor GAL-4 driving by a CMV promoter (pCMV-BD-SAMD4B). The luciferase reporter exhibited a basal level of transcriptional activity when transfected with the control plasmid pCMV-BD encoding the GAL4-DBD alone. LexA-VP16, which can directly activate the expression of the lucifer-http://bmbreports.org BMB reports
Fig. 2. SAMD4B is a transcription repressor. pCMV-BD-SAMD4B
or pCMV-BD is transiently co-transfected into COS-7 cells along with the pL8G5-Luc reporter and pLexA-VP16 as indicated in the figure. Forty eight hours later, the luciferase activity assay was performed. The data are means of three repeats in a single experiment after normalization for β-galactosidase activity. Each experiment was repeated at least three times.
ase reporter gene, was used as a positive control (13) . Cotransfecting with pL8G5-luc plasmid, the GAL4-SAMD4B fusion protein inhibited luciferase activity by approximately two-fold (Fig. 2) ; while co-transfecting with pLexA-VP16, the GAL4-SAMD4B fusion protein inhibited the VP16 activated luciferase activity by approximately six-fold (Fig. 2) , suggesting that SAMD4B is a potential transcription repressor.
SAMD4B suppresses the transcriptional activities of AP-1, p53 and p21, but has no effect on c-Jun SAM domain is a putative protein-protein interaction module present in a wide variety of proteins involved in many biological processes (8, 14) . To investigate the role of full-length SAMD4B and identify the key regulatory motifs in SAMD4B protein, Pathway-specific reporter gene assays were performed to measure the effect of SAMD4B on different pathways (such as AP-1, c-Jun, p53 and p21) in the HEK-293 cells. We found SAMD4B suppressed AP-1, p53 and p21 pathway more obviously than others. As shown in Fig. 3A , using pAP-1-Luc designed for monitoring induction of AP-1, full-length SAMD4B suppresses the AP-1-luciferase activity by ∼82%. The 5'DOMA, SAM and 3'DOMA motif of SAMD4B inhibited the luciferase activity by ∼28%, ∼71% and ∼48%, respectively (Fig. 3A) . Using p53-luc, which contains a luciferase gene under the . pCMV-Tag2B-SAMD4B or other truncated FLAG-SAMD4B fusion constructs (pCMVtag2B-5'DOMA, pCMV-tag2B-SAM, pCMV-tag2B-3'DOMA) were transiently co-transfected into HEK-293 cells along with the luciferase reporter gene (AP-1-Luc, p21-Luc, or p53-Luc), respectively. Fortyeight hours later, the luciferase activity assay was performed. The data are means of three repeats in a single experiment after normalization for β-galactosidase activity. http://bmbreports.org control of p53 response elements, the full-length and three truncated SAMD4B protein inhibited the luciferase activity by ∼66%, ∼20%, ∼54% and ∼23%, respectively (Fig. 3B) . Furthermore, using p21-luc, which encodes for luciferase controlled by p21, the full-length SAMD4B protein inhibited the luciferase activity by ∼73%, the three truncated SAMD4B protein inhibited the luciferase activity by ∼24%, ∼67% and ∼47%, respectively (Fig. 3C ). In addition, overexpressing full-length SAMD4B does not affect the c-Jun luciferase activity (Supplement Fig. 2 ). These results indicate that SAMD4B may potentially participates in the transcriptional repression involved in the AP-1, p53 and p21 signaling pathway in cells.
To further demonstrate the role of SAMD4B in cell signaling transduction, we used RNA interference to block the translation of SAMD4B. HEK-293 cells were transfected with one of two different pSUPER-silSAMD4B constructs (pSUPER-silSAMD4B1 and pSUPER-silSAMD4B2), together with pAP-1-Luc (p53-Luc or p21-Luc) and pCMVTag2B-SAMD4B, respectively. Both of the silSAMD4B sequences could relieve SAMD4B's repression of AP-1, p53 and p21 transcriptional activities (Fig. 4) .
Recently, studies focusing on the SAM domain containing proteins have suggested their extensive involvement in development, gene regulation, diseases and embryogenesis, such as p63 and p73, homologue of the tumour suppressor p53, are positively regulated in c-deficient tumors in response to oncogene over expression, and their expression are increased in several tumor types (11) . Both proteins have a SAM domain near their C-terminus, and deletion of the SAM domain of two proteins will work as tumour suppressor as p53, but complete protein of p63 and p73 can repress p53 pathway, so the SAM domain is thought to be responsible for regulating p53-like functions as a repressor (11, 12) . Our results indicated that the three domains (5'DOMA, SAM and 3'DOMA) contribute to the transcriptional repression by SAMD4B; in contrast, the effect by the SAM domain of SAMD4B seems to be more obviously than the other two DOMA domains.
AP-1 is a dimeric transcription factor composed of Jun, Fos or ATF (activating transcription factor) subunits and has been linked to modulation of p53 pathways to explain the role of AP-1 in cell survival. It is thought that AP-1(c-fos) is stimulated by p53 (17); p53 can activate the c-Jun NH2-terminal kinase (JNK) pathway to drive apoptosis (18) . We have shown that SAMD4B inhibits the transcription of AP-1 but does not affect transcriptional of c-Jun, suggesting that the repression of the AP-1(c-fos) may be indirectly caused through suppressing p53 by SAMD4B. It has been reported that p21 is one of the downstream genes of p53 and p53 that strongly induces p21 expression resulting in cell-cycle arrest (6); We examined the transcriptional effect of SAMD4B on p21 to confirm an effect of SAMD4B in the p53 pathway and the results suggest that SAMD4B suppresses p21 transcriptional activity, so we suppose that the similar repression of the p21 may be caused through suppressing p53 by SAMD4B. Our results suggested that SAMD4B may function as a negative transcriptional regulator in AP-1-p53 signaling pathways.
CONCLUSION
In summary, we have cloned a novel human SAM domain containing gene, SAMD4B. The deduced protein is composed of 694 amino acids. Phylogenetic tree analysis indicates that SAMD4B is a highly conserved protein. SAMD4B is expressed in multiple human tissues. SAMD4B protein is localized evenly in both the nucleus and the cytoplasm and acts as a transcriptional repressor. Overexpression of SAMD4B inhibits the transcriptional activities of AP-1, p53 and p21. Studies with truncated SAMD4B protein show that the SAM domain of SAMD4B is the main region for transcriptional suppression. Our studies suggested that SAMD4B might function as a negative transcriptional regulator in AP-1-p53 signaling pathways, which is known to affect cell cycle and apoptosis.
MATERIALS AND METHODS

Construction of cDNA library of human embryo heart
The total RNA from 20-week human embryo heart was extracted using standard methods. Briefly, 5 μg mRNA was purified from 500 μg total RNA using Rapid mRNA purification Kit (AMRESCO). Reverse transcription reactions were performed with the purified embryonic heart mRNA and oligo(dT)-RA primer according to cDNA Synthesis kit protocol. After Cassette Adaptor Ligation reactions using cDNA PCR Library Kit, cDNA amplification reactions were performed with RA primer, CA primer, and TaKaRa Ex Taq (19) .
Molecular cloning of SAMD4B and bioinformatics analysis
A search of the human EST database with the conserved SAM motifs was performed through a combined BLAST search as previously described (15, 16) . The obtained sequence was subjected to human homology searching against expressed sequence tag (EST) database using Blastn (http://www.ncbi.nlm. nih.gov/blast). We searched with the SAMD4B consensus sequence and identified five overlapping human expressed sequence tags (ESTs) (CR983898, BF768721, DN996769, CN394606 and CB852248) corresponding to a novel gene SAMD4B. The sequence of SAMD4B open-reading frame (ORF) was confirmed by PCR amplification with the gene-specific primer pair pORF1/pORF2 (Supplement material Table 1 ) based on the sequences of two contigs from ESTs, BU855513 and BF970676. The PCR products were cloned into pMD18-T-vector (Takara) and sequenced with 3770 DNA Sequencer (ABI PRISM). Sequence analysis was performed using the DNASTAR program and BLAST program from NCBI. Both the sequence alignment and phylogenetic tree analysis were performed with MegAlign program (DNASTAR).
Northern blot hybridization
The SAMD4B cDNA was used as a probe which was labeled with Digoxin (DDLK-010) using a random prime labeling kit (TaKaRa). An adult human Multiple Tissue Northern blot (Yinuojin of China) was hybridized to the labeled SAMD4B cDNA probe and β-actin cDNA probe (Clontech). Hybridization was carried out with 5×SSC, 5×Denhardt's, 10% dextran sulfate, and denatured human DNA, at 65 o C overnight. After hybridization, the blots were washed three times at 65 (20, 21) .
RNA isolation and RT-PCR
Human tissues from therapeutically aborted fetuses were obtained under the approval of Health Center of Changsha Women and Children Hospital, People's Republic of China, with the consent of the patients and under the regulation of university policy. Total RNA from various tissues (stomach, liver, kidney, spleen, urinary bladder, skin, heart, adrenal gland, intestine, pancreas and brain) was extracted using an RNA isolation kit (Invitrogen, Carlsbad, USA). cDNA was synthesized according to the instructions (Promega, Madison, USA) and was used as a template in the PCR amplification with the primer pair pRT1/pRT2 (Supplement material Table 1 ) and TaKaRa Ex Taq, GAPDH was amplified with primers Gs and Ga (Supplement material Table 1 ) as the control.
Plasmid construction
The L8G5-Luc, p53-Luc, p21-Luc and pAP-1-Luc constructs used were generated previously in the lab (20, 23) . The SAMD4B ORF was amplified by PCR with primers pE1 and pE2 (Supplement material Table 1 ) and was then subcloned into the EcoRI and BamHI sites of pEGFP-N2 vector with the GAG codon instead of the TAG stop codon. To generate a fusion protein of SAMD4B with GAL4 or FLAG tag, the SAMD4B ORF was amplified by PCR with primers pA1 and pA2 (Supplement Table  2 ) and then subcloned in-frame into the BamHI and EcoRI site of the pCMV-BD or pCMV-Tag2B, respectively. To generate a fusion protein of 5'DOMA (amino acids 1-297), SAM (amino acids 302-373) and 3'DOMA (amino acids 382-694) fragments with FLAG tag, the three fragments were amplified by PCR with primers pA1/pB1, pC1/pC2, pD1/pA2 (Supplement Table  1) , respectively, and then subcloned to the BamHI and EcoRI sites of the pCMV-Tag2B. http://bmbreports.org Cell culture and subcellular localization analysis COS-7 cells and HEK-293 cells used in all studies were maintained and passaged according to standard methods described previously (24) . Cells were transfected with pEGFP-N2-SAMD4B plasmid DNA using Lipofectamine 2000 (Invitrogen, Carlsbad, USA) according to the manufacturer's instructions. Forty-eight hours after the transfection, Subcellular localization of the fusion protein (EGFP-SAMD4B) was detected by fluorescence microscopy (Nikon, E400) after labeling with DAPI for nuclei. The COS-7 cells transfected with pEGFP-N2 vector were used as a control.
Transient expression reporter gene assay
To investigate the effect of SAMD4B on transcriptional activity, pCMV-BD-SAMD4B was transiently co-transfected into COS-7 cells along with the pL8G5-Luc reporter and pLexA-VP-16 as described above. The luciferase activity assay was performed 48 h later according to the methods described previously (23) .
To investigate the effect of SAMD4B on the transcriptional activity of the pathway-specific reporter gene (such as AP-1-Luc, p21-Luc, p53-Luc and c-Jun-Luc), pCMV-Tag2B-SAMD4B or other truncated FLAG-SAMD4B fusion constructs were transiently co-transfected into HEK-293 cells along with the luciferase reporter gene (AP-1-Luc, p21-Luc, p53-Luc or c-Jun-Luc), respectively. Luciferase activity was assayed as described previously, and each assay was repeated at least three times.
RNAi analysis
A pSUPER.retro.puro vector-based system was used to deliver siRNA into HEK-293 cells (25) . Pairs of oligonucleotides were designed by the RNAi program (http://www.openbiosystems. com/RNAi) and two nucleotide (nt) sequences specific for SAMD4B (silSAMD4B-1: CCAGACACAATCTCTATGAGT; silSAMD4B-2: GCAGAAGAAACGGCTGCTA) are selected. Each pair of the forward and reverse oligos (silSAMD4B-s1/silSAMD4B-anti-s1 and silSAMD4B-s2/silSAMD4B-anti-s2, Supplement material Table 1 ) was annealed and inserted into the pSUPER.retro. puro vector between the BglII and XhoI enzyme sites, respectively. The Luciferase activity assay for the reporter gene (AP-1-Luc, p21-Luc or p53-Luc), pCMV-Tag2B-SAMD4B, and pSUPER silSAMD4B, or pSUPER.retro.puro vector was performed according to the protocols described above.
